Zobrazeno 1 - 10
of 128
pro vyhledávání: '"Seong Hyun, Jeong"'
Autor:
Ho-Young Yhim, Yong Park, Jeong-A Kim, Ho-Jin Shin, Young Rok Do, Joon Ho Moon, Min Kyoung Kim, Won Sik Lee, Dae Sik Kim, Myung-Won Lee, Yoon Seok Choi, Seong Hyun Jeong, Kyoung Ha Kim, Jinhang Kim, Chang-Hoon Lee, Ga-Young Song, Deok-Hwan Yang, Jae-Yong Kwak
Publikováno v:
The Korean Journal of Internal Medicine, Vol 39, Iss 3, Pp 501-512 (2024)
Background/Aims Optimal risk stratification based on simplified geriatric assessment to predict treatment-related toxicity and survival needs to be clarified in older patients with diffuse large B-cell lymphoma (DLBCL). Methods This multicenter prosp
Externí odkaz:
https://doaj.org/article/776c9c0704b945f3bb578ac1fc298d96
Autor:
Yunlin Zhang, Ruchi P. Patel, Ki Hyun Kim, Hyungwoo Cho, Jae-Cheol Jo, Seong Hyun Jeong, Sung Yong Oh, Yoon Seok Choi, Sung Hyun Kim, Ji Hyun Lee, Mathew Angelos, Puneeth Guruprasad, Ivan Cohen, Ositadimma Ugwuanyi, Yong Gu Lee, Raymone Pajarillo, Jong Hyun Cho, Alberto Carturan, Luca Paruzzo, Guido Ghilardi, Michael Wang, Soohwan Kim, Sung-Min Kim, Hyun-Jong Lee, Ji-Ho Park, Leiguang Cui, Tae Bum Lee, In-Sik Hwang, Young-Ha Lee, Yong-Jun Lee, Patrizia Porazzi, Dongfang Liu, Yoon Lee, Jong-Hoon Kim, Jong-Seo Lee, Dok Hyun Yoon, Junho Chung, Marco Ruella
Publikováno v:
Molecular Cancer, Vol 22, Iss 1, Pp 1-23 (2023)
Abstract Background Commercial anti-CD19 chimeric antigen receptor T-cell therapies (CART19) are efficacious against advanced B-cell non-Hodgkin lymphoma (NHL); however, most patients ultimately relapse. Several mechanisms contribute to this failure,
Externí odkaz:
https://doaj.org/article/f352f6b7f911417286a5dd19eb392756
Autor:
Hyerim Ha, Yeh-Hee Ko, Kwangsoo Kim, Junshik Hong, Gyeong-Won Lee, Seong Hyun Jeong, Soo-Mee Bang, Sung-Soo Yoon
Publikováno v:
Thrombosis Journal, Vol 21, Iss 1, Pp 1-8 (2023)
Abstract Background The Khorana score (KS) has not been well studied in East Asian cancer patients, who have different genetic backgrounds for inherited thrombophilia, body metabolism, and cancer epidemiology. Methods By using the Common Data Model,
Externí odkaz:
https://doaj.org/article/c0aeda4cc8284e46aa27459a1205e054
Autor:
Seok Jin Kim, Jae-Cheol Jo, Dok Hyun Yoon, Deok-Hwan Yang, Sang Eun Yoon, Gyeong-Won Lee, Jee Hyun Kong, Yong Park, Ka-Won Kang, Ho-Sup Lee, Sung Yong Oh, Ho-Jin Shin, Won Sik Lee, Yoon Seok Choi, Seong Hyun Jeong, Min Kyoung Kim, Hye Jin Kang, Jun Ho Yi, Sung-Nam Lim, Ho-Young Yhim, Young Rok Do, Hwan Jung Yun, Hyeon-Seok Eom, Mark Hong Lee, Cheolwon Suh, Won Seog Kim
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionUpfront autologous stem cell transplantation (ASCT) has been recommended for patients who are newly diagnosed with peripheral T-cell lymphoma (PTCL), and CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone), an anthracycline-
Externí odkaz:
https://doaj.org/article/3ac432a63fad4f94935c09078e6069be
Autor:
Jin-Hyuk Choi, Yong Won Choi, Seok Yun Kang, Geum Sook Jeong, Hyun Woo Lee, Seong Hyun Jeong, Joon Seong Park, Mi Sun Ahn, Seung Soo Sheen
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background Although combination chemotherapy (CC) is generally recommended in recurrent or primary metastatic gastric cancer (RPMGC), the results of randomized trials are conflicting. Methods A retrospective review was conducted on 687 RPMGC
Externí odkaz:
https://doaj.org/article/cd68838292f94f4797ed4a90c81c76ee
Autor:
Jun Ho Yi1, Seong Hyun Jeong2, Seok Jin Kim3, Dok Hyun Yoon4, Hye Jin Kang5, Youngil Koh6, Jin Seok Kim7, Won-Sik Lee8, Deok-Hwan Yang9, Young Rok Do10, Min Kyoung Kim11, Kwai Han Yoo12, Yoon Seok Choi2, Whan Jung Yun13, Yong Park14, Jae-Cheol Jo15, Hyeon-Seok Eom16, Jae-Yong Kwak17, Ho-Jin Shin18, Byeong Bae Park19
Publikováno v:
Cancer Research & Treatment. Jan2023, Vol. 55 Issue 1, p325-333. 9p.
Autor:
Sung Yong Oh, Won Seog Kim, Jin Seok Kim, Seok Jin Kim, Dok Hyun Yoon, Deok-Hwan Yang, Won Sik Lee, Hyo Jung Kim, Ho-Young Yhim, Seong Hyun Jeong, Jong Ho Won, Suee Lee, Jee Hyun Kong, Sung-Nam Lim, Jun Ho Ji, Kyung A. Kwon, Gyeong-Won Lee, Jae Hoon Lee, Ho Sup Lee, Ho-Jin Shin, Cheolwon Suh
Publikováno v:
Cancer Communications, Vol 39, Iss 1, Pp 1-10 (2019)
Abstract Background The response rate and survival improvement for rituximab, a CD20-targeting monoclonal antibody, have been demonstrated in marginal zone lymphoma (MZL) as monotherapy and in combination with chemotherapeutic regimens, yet relapses
Externí odkaz:
https://doaj.org/article/71b67af39974455eabfbdea3ff3dbe0d
Autor:
Seong Hyun Jeong1, Seok Jin Kim2, Dok Hyun Yoon3, Yong Park4, Hye Jin Kang5, Youngil Koh6, Gyeong-Won Lee7, Won-Sik Lee8, Deok-Hwan Yang9, Young Rok Do10, Min Kyoung Kim11, Kwai Han Yoo12, Yoon Seok Choi1, Hwan Jung Yun13, Jun Ho Yi14, Jae-Cheol Jo15, Hyeon-Seok Eom16, Jae-Yong Kwak17, Ho-Jin Shin18, Byeong Bae Park19
Publikováno v:
Cancer Research & Treatment. Oct2022, Vol. 54 Issue 4, p1268-1277. 10p.
Autor:
Hyungwoo, Cho, Dok Hyun, Yoon, Dong-Yeop, Shin, Youngil, Koh, Sung-Soo, Yoon, Seok Jin, Kim, Young Rok, Do, Gyeong-Won, Lee, Jae-Yong, Kwak, Yong, Park, Min Kyoung, Kim, Hye Jin, Kang, Jun Ho, Yi, Kwai Han, Yoo, Won Sik, Lee, Byeong Bae, Park, Jae-Cheol, Jo, Hyeon-Seok, Eom, Hyo Jung, Kim, Seong Hyun, Jeong, Young-Woong, Won, Byeong Seok, Sohn, Ji-Hyun, Kwon, Cheolwon, Suh, Won Seog, Kim
Publikováno v:
Cancer Research and Treatment. 55:684-692
Purpose We conducted a nationwide, multicenter, prospective registry study for newly diagnosed patients with peripheral T-cell lymphoma (PTCL) to better define the clinical characteristics, treatment patterns, survival outcomes, and the role of upfro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::942358eff3f8327eb0c396541669754d
https://doi.org/10.4143/crt.2022.1434
https://doi.org/10.4143/crt.2022.1434
Autor:
Jin Roh, Hyo-Kyung Pak, Seongfeel Jeong, Sewon Hwang, Do Eon Kim, Hwal-Seok Choi, So-Jeong Kim, Hyunji Kim, Hyungwoo Cho, Joon Seong Park, Seong Hyun Jeong, Yoon Seok Choi, Jae Ho Han, Dok Hyun Yoon, Chan-Sik Park
Diffuse large B-cell lymphoma (DLBCL) is a prevalent and aggressive non-Hodgkin’s lymphoma, and 40% of patients succumb to death. Despite numerousclinical trials aimed at developing treatment strategies beyond the conven-tional R-CHOP (rituximab, c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::757ed3cdd581758aff0c5f32e96ae4ef
https://doi.org/10.21203/rs.3.rs-2857911/v1
https://doi.org/10.21203/rs.3.rs-2857911/v1
